9.11
-0.08
(-0.87%)
At close: January 31 at 8:16:34 AM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DONHAUSER PETER D.O. Director | Purchase | Jun 14, 2024 | 5,000 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security | Mar 28, 2024 | 1,250,210 |
| THOMAS STEFFEN PHD Director | Purchase | May 15, 2024 | 5,000 |
Related Tickers
19X.SG Axsome Therapeutics Inc
102.25
-2.01%
I9SA.HA Verona Pharma PLC
55.00
+0.92%
TRRI Alzex Neuropharma Inc.
0.1980
0.00%
HALB Halberd Corporation
0.0034
+13.33%
RAPP Rapport Therapeutics, Inc.
16.41
-1.44%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
PCVX Vaxcyte, Inc.
88.32
-3.95%
DAWN Day One Biopharmaceuticals, Inc.
12.37
-3.81%
IBIO iBio, Inc.
3.0100
+1.35%
CELZ Creative Medical Technology Holdings, Inc.
3.1300
-7.40%